Free Trial

Structure Therapeutics (GPCR) SEC Filings & 10K Form

Structure Therapeutics logo
$32.71 -0.07 (-0.21%)
(As of 11/20/2024 ET)

Recent Structure Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
4:46 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
11/14/2024
9:26 AM
JANUS HENDERSON GROUP PLC (Filed by)
Structure Therapeutics (Subject)
Form SC 13G
11/14/2024
8:33 AM
Avoro Capital Advisors LLC (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
11/13/2024
3:16 PM
Structure Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
9:34 AM
FMR LLC (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
11/08/2024
9:52 AM
Structure Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
09/20/2024
4:41 PM
Coll Crespo Blas (Reporting)
Structure Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/20/2024
4:42 PM
Coll Crespo Blas (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
4:45 PM
Hall Ashley (Reporting)
Structure Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/20/2024
4:47 PM
Hall Ashley (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2024
3:35 PM
Russell Angus C. (Reporting)
Structure Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/28/2024
3:37 PM
Russell Angus C. (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:16 PM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:23 PM
Structure Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/27/2024
4:00 PM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
3:15 PM
Structure Therapeutics (Issuer)
WELCH DANIEL G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:15 PM
Structure Therapeutics (Issuer)
TETLOW SHARON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:15 PM
DOBMEIER ERIC (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:15 PM
Structure Therapeutics (Issuer)
Waldstreicher Joanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:15 PM
LOVE TED W (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
7:19 PM
Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:07 AM
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/12/2024
3:42 PM
Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
4:07 PM
Stevens Raymond C (Reporting)
Structure Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
11:15 PM
Structure Therapeutics (Filer)
Form EFFECT
06/05/2024
6:38 PM
Lin Xichen (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
6:43 PM
Structure Therapeutics (Filer)
Form S-1MEF
06/03/2024
7:00 AM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2024
5:57 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Structure Therapeutics (Subject)
Form SC 13G
05/09/2024
3:56 PM
Structure Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
3:10 PM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
4:24 PM
Structure Therapeutics (Filer)
Form ARS
04/19/2024
1:13 PM
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
6:34 PM
Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
Form 4/A
03/20/2024
6:37 PM
Structure Therapeutics (Issuer)
Yoon Jun (Reporting)
Form 4/A
03/20/2024
6:39 PM
Ma Yingli (Reporting)
Structure Therapeutics (Issuer)
Form 4/A
03/20/2024
6:41 PM
Bach Mark Allen (Reporting)
Structure Therapeutics (Issuer)
Form 4/A
03/20/2024
6:42 PM
Lin Xichen (Reporting)
Structure Therapeutics (Issuer)
Form 4/A
03/19/2024
3:36 PM
Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:52 AM
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:19 PM
Structure Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
Financial Prophecy (Ad)

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.
03/08/2024
8:19 AM
Structure Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/08/2024
7:43 AM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
10:11 AM
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
8:07 AM
Avoro Capital Advisors LLC (Filed by)
Structure Therapeutics (Subject)
Form SC 13G
02/14/2024
7:45 AM
Deep Track Capital, LP (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
02/09/2024
8:49 AM
FMR LLC (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
02/09/2024
6:59 AM
FIL Ltd (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
02/06/2024
10:01 AM
Structure Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
12/27/2023
9:49 AM
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
9:49 AM
FMR LLC (Reporting)
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:36 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
12/18/2023
7:28 AM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
10:04 AM
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
11:15 PM
Structure Therapeutics (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:GPCR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners